2023
Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trial
Edelman E, Dziura J, Deng Y, DePhilippis D, Fucito L, Ferguson T, Bedimo R, Brown S, Marconi V, Goetz M, Rodriguez-Barradas M, Simberkoff M, Molina P, Weintrob A, Maisto S, Paris M, Justice A, Bryant K, Fiellin D. Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trial. Contemporary Clinical Trials 2023, 131: 107242. PMID: 37230168, PMCID: PMC10460633, DOI: 10.1016/j.cct.2023.107242.Peer-Reviewed Original ResearchConceptsUnhealthy alcohol useLong-term abstinenceAlcohol useContingency managementAlcohol consumptionFormal alcohol treatmentShort-term abstinenceMotivational enhancement therapyGOV IDENTIFIERSecondary outcomesWeek 24Primary outcomeWeek 12Preliminary efficacyTreatment trialsPhysician managementEfficacy trialsMedical conditionsAlcohol treatmentExploratory outcomesEnhancement therapyAbstinenceTrialsCareHealthy activitiesA Secondary Analysis of a Preliminary Contingency Management Intervention for Presurgical Cancer Patients: Evaluating Individual Participant Data
Sanford B, Toll B, Fucito L, Baker N, Krishnan-Sarin S, Carpenter M, Bernstein S, Rojewski A. A Secondary Analysis of a Preliminary Contingency Management Intervention for Presurgical Cancer Patients: Evaluating Individual Participant Data. Nicotine & Tobacco Research 2023, 25: 1614-1618. PMID: 37156634, PMCID: PMC10439489, DOI: 10.1093/ntr/ntad071.Peer-Reviewed Original ResearchConceptsContingency management interventionSustained abstinenceMonetary reinforcersMO participantsBehavior patternsManagement interventionsSuccessful abstinenceIndividual behavior patternsSchedule of reinforcementIndividual participantsSecondary analysisAbstinenceEffect sizeEveryday smokersParticipantsFinancial reinforcementVerified abstinenceCM interventionReinforcersCancer patientsInterventionBreath COCM groupExact testLapse
2022
Urgent Need for Novel Investigations of Treatments to Quit E-cigarettes: Findings from a Systematic Review
Palmer AM, Price SN, Foster MG, Sanford BT, Fucito LM, Toll BA. Urgent Need for Novel Investigations of Treatments to Quit E-cigarettes: Findings from a Systematic Review. Cancer Prevention Research 2022, 15: 569-580. PMID: 35816038, PMCID: PMC9444997, DOI: 10.1158/1940-6207.capr-22-0172.Peer-Reviewed Original ResearchConceptsE-cigarette cessationE-cigarettesSystematic reviewE-cigarette useSymptoms of dependenceCohort studyCigarette smokingPsychologic factorsQuit attemptsHealth concernCessationCold turkeySmokingLack of satisfactionHigher intentFuture studiesAdultsInterventionAdult samplesUrgent needLack of informationReviewSymptomsAbstinenceIndividuals
2018
A Pilot Clinical Trial of Smoking Cessation Services Implemented in the Workplace for Service Industry Employees
Bold KW, Kimmel L, Hanrahan TH, Romano D, Rojewski AM, Krishnan-Sarin S, Fucito LM, O’Malley S. A Pilot Clinical Trial of Smoking Cessation Services Implemented in the Workplace for Service Industry Employees. American Journal Of Health Promotion 2018, 33: 516-524. PMID: 30153737, PMCID: PMC7259449, DOI: 10.1177/0890117118795987.Peer-Reviewed Original ResearchConceptsSmoking cessation servicesService industry employeesCessation servicesQuit attemptsIndustry employeesEvidence-based tobacco treatmentPilot clinical trialEnd of treatmentFree pharmacotherapyTobacco treatmentPreliminary efficacyHelpful overallClinical trialsSmoking treatmentSuccessful abstinenceContingency managementEmployeesIndividual counselingTreatmentStatus SurveyPrimary measureService settingsHigh rateWorkplaceAbstinence
2016
Nicotine Replacement Therapy Use Predicts Smoking and Drinking Outcomes among Heavy-Drinking Smokers Calling a Tobacco Quitline
Rojewski AM, Fucito LM, Baldassarri S, Hyland A, Cummings KM, Toll BA. Nicotine Replacement Therapy Use Predicts Smoking and Drinking Outcomes among Heavy-Drinking Smokers Calling a Tobacco Quitline. The Journal Of Smoking Cessation 2016, 12: 99-104. PMID: 35082926, PMCID: PMC8788683, DOI: 10.1017/jsc.2016.12.Peer-Reviewed Original ResearchNicotine replacement therapyHeavy drinking daysDrinking daysNRT useFree nicotine replacement therapyNicotine replacement therapy useHeavy drinking smokersState Smokers' QuitlineTobacco counsellingTherapy useCessation assistanceSmoking statusReplacement therapyTobacco quitlineSmoking abstinenceHazardous drinkersSmokersQuitlineHeavy drinkingSuboptimal useDrinking outcomesAbstinenceDaysCounsellingSignificant barriers
2015
An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate
Gueorguieva R, Wu R, Tsai WM, O’Connor P, Fucito L, Zhang H, O’Malley S. An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate. European Neuropsychopharmacology 2015, 25: 1586-1599. PMID: 26141511, PMCID: PMC4600651, DOI: 10.1016/j.euroneuro.2015.06.006.Peer-Reviewed Original ResearchConceptsAcamprosate effectHeavy drinkingShort abstinenceEnhanced treatment responseMonths of treatmentSubgroup of patientsBody mass indexDrug plasma levelsIdentification of subgroupsBetter prognosisLower BMIMass indexPlasma levelsGlutamatergic hyperactivityTreatment responseAcamprosateCOMBINE StudyPrior treatmentLarger studyConsecutive daysAbstinencePretreatment abstinenceTreatment effectsCognitive inefficiencySubgroups